XML 17 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Operating activities      
Net loss $ (118,016) $ (875,377)  
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 65,431 77,214  
Amortization of deferred financing costs and debt discount 5,796 3,698  
Straight-line rent revenue from operating and finance leases (41,601) (46,566)  
Stock / Unit-based compensation expense 17,665 7,633  
(Gain) loss on sale of real estate (8,059) 1,423  
Real estate and other impairment charges, net 79,581 694,905  
Debt refinancing and unutilized financing costs 3,796 0  
Tax rate changes and other 1,102 (307)  
Non-cash fair value adjustments 26,609 221,276  
Other adjustments 2,473 2,398  
Changes in:      
Interest and rent receivables 6,626 5,369  
Other assets (1,792) 5,689  
Accounts payable and accrued expenses (35,400) (18,878)  
Deferred revenue (3,827) (4,135)  
Net cash provided by operating activities 384 74,342  
Investing activities      
Cash paid for acquisitions and other related investments (39,314)    
Net proceeds from sale of real estate 19,837 6,596  
Proceeds received from sale and repayment of loans receivable 0 114,416  
Investment in loans receivable (21,800) (135,000)  
Construction in progress and other (26,053) (29,885)  
Proceeds from sale and return of equity investments 0 11,656  
Capital additions and other investments, net (22,086) (87,045)  
Net cash used for investing activities (89,416) (119,262)  
Financing activities      
Proceeds from term debt 2,512,970 0  
Payments of term debt (2,252,731) 0  
Revolving credit facility, net 258,433 111,186  
Dividends / Distribution paid (48,164) (92,763)  
Lease deposits and other obligations to tenants 3,243 6,226  
Stock / Unit vesting - satisfaction of tax withholdings (289) (283)  
Payment of debt refinancing and deferred financing costs and other financing activities (47,142) (2,291)  
Net cash provided by financing activities 426,320 22,075  
Increase (decrease) in cash, cash equivalents, and restricted cash for period 337,288 (22,845)  
Effect of exchange rate changes 4,024 (2,889)  
Cash, cash equivalents, and restricted cash at beginning of period 335,173 255,952 $ 255,952
Cash, cash equivalents, and restricted cash at end of period 676,485 230,218 335,173
Interest paid 118,005 131,815  
Supplemental schedule of non-cash financing activities:      
Dividends / Distributions declared, unpaid 48,387 0  
Cash, cash equivalents, and restricted cash are comprised of the following:      
Cash and cash equivalents at beginning of period 332,335 250,016 250,016
Restricted cash, included in Other assets at beginning of period $ 2,838 $ 5,936 $ 5,936
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets Other Assets
Cash, cash equivalents, and restricted cash at beginning of period $ 335,173 $ 255,952 $ 255,952
Cash and cash equivalents at end of period 673,482 224,340 332,335
Restricted cash, included in Other assets at end of period $ 3,003 $ 5,878 $ 2,838
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets Other Assets
Cash, cash equivalents, and restricted cash at end of period $ 676,485 $ 230,218 $ 335,173
MPT Operating Partnership, L.P. [Member]      
Operating activities      
Net loss (118,016) (875,377)  
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 65,431 77,214  
Amortization of deferred financing costs and debt discount 5,796 3,698  
Straight-line rent revenue and other (41,601) (46,566)  
Stock / Unit-based compensation expense 17,665 7,633  
(Gain) loss on sale of real estate (8,059) 1,423  
Real estate and other impairment charges, net 79,581 694,905  
Debt refinancing and unutilized financing costs 3,796 0  
Tax rate changes and other 1,102 (307)  
Non-cash fair value adjustments 26,609 221,276  
Other adjustments 2,473 2,398  
Changes in:      
Interest and rent receivables 6,626 5,369  
Other assets (1,792) 5,689  
Accounts payable and accrued expenses (35,400) (18,878)  
Deferred revenue (3,827) (4,135)  
Net cash provided by operating activities 384 74,342  
Investing activities      
Cash paid for acquisitions and other related investments (39,314)    
Net proceeds from sale of real estate 19,837 6,596  
Proceeds received from sale and repayment of loans receivable 0 114,416  
Investment in loans receivable (21,800) (135,000)  
Construction in progress and other (26,053) (29,885)  
Proceeds from sale and return of equity investments 0 11,656  
Capital additions and other investments, net (22,086) (87,045)  
Net cash used for investing activities (89,416) (119,262)  
Financing activities      
Proceeds from term debt 2,512,970 0  
Payments of term debt (2,252,731) 0  
Revolving credit facility, net 258,433 111,186  
Dividends / Distribution paid (48,164) (92,763)  
Lease deposits and other obligations to tenants 3,243 6,226  
Stock / Unit vesting - satisfaction of tax withholdings (289) (283)  
Payment of debt refinancing and deferred financing costs and other financing activities (47,142) (2,291)  
Net cash provided by financing activities 426,320 22,075  
Increase (decrease) in cash, cash equivalents, and restricted cash for period 337,288 (22,845)  
Effect of exchange rate changes 4,024 (2,889)  
Cash, cash equivalents, and restricted cash at beginning of period 335,173 255,952 255,952
Cash, cash equivalents, and restricted cash at end of period 676,485 230,218 335,173
Interest paid 118,005 131,815  
Supplemental schedule of non-cash financing activities:      
Dividends / Distributions declared, unpaid 48,387 0  
Cash, cash equivalents, and restricted cash are comprised of the following:      
Cash and cash equivalents at beginning of period 332,335 250,016 250,016
Restricted cash, included in Other assets at beginning of period $ 2,838 $ 5,936 $ 5,936
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets Other Assets
Cash, cash equivalents, and restricted cash at beginning of period $ 335,173 $ 255,952 $ 255,952
Cash and cash equivalents at end of period 673,482 224,340 332,335
Restricted cash, included in Other assets at end of period $ 3,003 $ 5,878 $ 2,838
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets Other Assets
Cash, cash equivalents, and restricted cash at end of period $ 676,485 $ 230,218 $ 335,173